A Phase 1b/2 Open Label Umbrella Study of Sasanlimab Combined with Anti-Cancer Therapies Targeting Multiple Molecular Mechanisms in Participants with Non-Small Cell Lung Cancer (NSCLC)

March 15, 2021
https://clinicaltrials.gov/ct2/show/NCT04585815
Cancer - Lung
Principal Investigator: Shirish M Gadgeel, MD
Lung, Non small cell
In Progress